S0500 Treatment Decision Making Based on Blood Levels of Tumor Cells for Metastatic Breast Cancer Treated With Chemo
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Daniel F. Hayes, MD
University of Michigan Rogel Cancer Center
Study Chair - Jeffrey B. Smerage, MD, PhD
University of Michigan Rogel Cancer Center
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
296 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Regional Medical Center
Anniston, Alabama, United States
- Alaska Regional Hospital Cancer Center
Anchorage, Alaska, United States
- Providence Cancer Center
Anchorage, Alaska, United States
- Nea Medical Center - Stadium Boulevard
Jonesboro, Arkansas, United States
- Glendale Memorial Hospital Comprehensive Cancer Center
Glendale, California, United States
- California Cancer Care, Incorporated - Greenbrae
Greenbrae, California, United States
- Loma Linda University Cancer Institute at Loma Linda University Medical Center
Loma Linda, California, United States
- Usc/norris Comprehensive Cancer Center and Hospital
Los Angeles, California, United States
- Camino Medical Group - Treatment Center
Mountain View, California, United States
- Palo Alto Medical Foundation
Palo Alto, California, United States
- Stanford Cancer Center
Stanford, California, United States
- San Luis Valley Regional Medical Center
Alamosa, Colorado, United States
- University of Colorado Cancer Center at Uc Health Sciences Center
Aurora, Colorado, United States
- Veterans Affairs Medical Center - Denver
Denver, Colorado, United States
- Shaw Regional Cancer Center
Edwards, Colorado, United States
- Valley View Hospital Cancer Center
Glenwood Springs, Colorado, United States
- St. Mary'S Regional Cancer Center at St. Mary'S Hospital and Medical Center
Grand Junction, Colorado, United States
- Montrose Memorial Hospital Cancer Center
Montrose, Colorado, United States
- Saint Francis/mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut, United States
- Yale Cancer Center
New Haven, Connecticut, United States
- Florida Hospital Cancer Institute at Florida Hospital Orlando
Orlando, Florida, United States
- Pearlman Comprehensive Cancer Center at South Georgia Medical Center
Valdosta, Georgia, United States
- Cancer Research Center of Hawaii
Honolulu, Hawaii, United States
- Hawaii Medical Center - East
Honolulu, Hawaii, United States
- Kapiolani Medical Center for Women and Children
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Kuakini
Honolulu, Hawaii, United States
- Oncare Hawaii, Incorporated - Lusitana
Honolulu, Hawaii, United States
- Queen'S Cancer Institute at Queen'S Medical Center
Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Incorporated
Honolulu, Hawaii, United States
- Tripler Army Medical Center
Honolulu, Hawaii, United States
- Maui Memorial Medical Center
Wailuku, Hawaii, United States
- Pacific Cancer Institute - Maui
Wailuku, Hawaii, United States
- Kapiolani Medical Center at Pali Momi
‘Aiea, Hawaii, United States
- Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho, United States
- Rush-Copley Cancer Care Center
Aurora, Illinois, United States
- Louis A. Weiss Memorial Hospital
Chicago, Illinois, United States
- Resurrection Medical Center
Chicago, Illinois, United States
- Elmhurst Memorial Hospital
Elmhurst, Illinois, United States
- Ingalls Cancer Care Center at Ingalls Memorial Hospital
Harvey, Illinois, United States
- Swedish-American Regional Cancer Center
Rockford, Illinois, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Oct 2006
- Primary completion
- 31 Dec 2015
- Completion
- 11 Jul 2017
- Last update posted
- 6 Nov 2017
- Registered enrollment
- 624
- Registry id
- NCT00382018
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.